Origin Biomed Us Inc is categorized under Drugs, Proprietaries, and Sundries in Tulsa, OK and active since 2007.
Origin Biomed Us Inc was established in 2007, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Drugs, Proprietaries, and Sundries business, which does work in the B2C market, and is classified as a Drugs, Proprietaries, and Sundries, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Chuck A Liston at the company’s single location by writing to 11701 South Sandusky Avenue, Tulsa, Oklahoma OK 74137 or by phoning (425) 415-6028. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Origin Biomed Us Inc |
| Contact Person: | Chuck A Liston |
| Address: | 11701 South Sandusky Avenue, Tulsa, Oklahoma 74137 |
| Phone Number: | (425) 415-6028 |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Drugs, Proprietaries, and Sundries |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Origin Biomed Us Inc was started in 2007 to provide professional Drugs, Proprietaries, and Sundries under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Chuck A Liston for inquiries that concern Origin Biomed Us Inc by calling the company number (425) 415-6028, as your correspondence is most welcome. Additionally, the physical location of the single location of Origin Biomed Us Inc can be found at the coordinates as well as the street address 11701 South Sandusky Avenue in Tulsa, Oklahoma 74137.
For its online presence, you may visit Origin Biomed Us Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.